| Net Cash Provided by (Used in) Operating Activities |
$54,821,000 |
USD |
-52% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$4,548,000 |
USD |
-24% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$25,417,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$24,856,000 |
USD |
90% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$261,745,000 |
USD |
80% |
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Valuation Allowance |
$362,495,000 |
USD |
65% |
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Gross |
$362,765,000 |
USD |
65% |
Q4 2025 |
FY 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$422,965,000 |
USD |
-62% |
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$139,120,000 |
USD |
145% |
Q4 2025 |
FY 2025 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q4 2025 |
FY 2025 |
| Preferred Stock, Shares Authorized |
10,000,000 |
shares |
0% |
Q4 2025 |
FY 2025 |
| Unrecognized Tax Benefits |
$0 |
USD |
|
Q4 2025 |
FY 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$270,000 |
USD |
|
Q4 2025 |
FY 2025 |
| Share-based Payment Arrangement, Expense |
$86,502,000 |
USD |
43% |
Q4 2025 |
FY 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0.0001 |
USD/shares |
0% |
Q4 2025 |
FY 2025 |